AAV8 Virus-Like Particles (Empty Capsids)

AAV8 stands for adeno-associated virus serotype 8. It is one of the many serotypes of adeno-associated virus (AAV) used in gene therapy. AAVs are small viruses that infect humans and some other primates, but it is not clear whether they cause disease. They are designed to deliver therapeutic genes to cells because they can effectively target specific tissues and have a relatively low risk of causing an immune response. AAV8 is very effective in targeting hepatocytes, making it an attractive option for gene therapies aimed at treating liver-related diseases. It is also able to transduce muscle and some other tissues relatively efficiently. The concept of virus-like particles (VLPs) is used in various fields, including vaccine development, drug delivery, and molecular biology research. These particles mimic the structure of natural viruses without the risk of viral replication or disease transmission, providing a safe and effective platform for a variety of applications. AAV8 virus-like particles are empty capsids of AAV serotype 8 that do not contain any genomic material. In gene therapy studies, empty AAV8 capsids are used as controls in experiments evaluating the efficacy and safety of AAV-based therapies. They help distinguish the effects of the capsid itself from those of the therapeutic gene. Additionally, empty capsids are useful in examining the biodistribution and pharmacokinetics of AAV particles in vivo , providing insight into how these vectors navigate and distribute in biological systems.